Keyphrases
Carraguard
100%
Papillomavirus Infections
85%
Phase II Trial
85%
High-risk Human Papillomavirus (HR-HPV)
67%
Cervical Cancer
20%
Population Council
15%
Medical Center
15%
Bronx
15%
Cervicovaginal Lavage
15%
Albert Einstein
15%
School of Medicine
15%
Microbicides
12%
New Humanities
12%
Abnormal Pap Test
12%
Formulation Vehicle
9%
Shared Vision
9%
Anti-HIV Agents
9%
Pseudovirion
9%
Vaginal Microbicides
7%
Vaginal Swab
7%
Female Genital Tract
7%
Genital Tract
7%
Sexually Transmitted Infections
7%
Effective Combination
7%
One Year Period
7%
Efficacy Trial
7%
Public Hospitals
7%
Mechanism of Activity
7%
Antiviral Activity
7%
Placebo Groups
7%
Vaginal Microbiome
7%
Repeated Application
7%
Cervical Intraepithelial Neoplasia
7%
Clinical Trials
7%
Early Adoption
7%
Seminal Plasma
7%
Infection Prevention
7%
Randomized Double-blind Placebo-controlled Study
7%
HIV Infection in Women
7%
Jacobi
7%
New York
7%
Sexually Transmitted Infection Prevention
7%
Manhattan
7%
Animal Model Study
7%
Combination Microbicide
7%
HIV Infection
7%
Further Development
7%
University Hospital
7%
Public Health
5%
Medicine and Dentistry
Carrageenan
100%
Papillomavirus Infection
85%
Phase II Trials
85%
Wart Virus
67%
Microbicide
28%
Cervical Cancer
20%
Population Council
18%
Human Immunodeficiency Virus
15%
Medicine
15%
Lavage
15%
Human Immunodeficiency Virus Infection
15%
Papanicolaou Stain
12%
Seminal Plasma
9%
Anti Human Immunodeficiency Virus Agent
9%
Arm
7%
Epileptic Absence
7%
Secretion (Process)
7%
Cervical Intraepithelial Neoplasia
7%
Antiviral Activity
7%
Clinical Trial
7%
In Vitro
7%
Placebo-Controlled Study
7%
Placebo
7%
Infection Prevention
7%
Ex Vivo
7%
Pharmacology, Toxicology and Pharmaceutical Science
Papillomavirus Infection
85%
Phase II Trials
85%
Carrageenan
85%
Human Papillomavirus
67%
Microbicide
28%
Uterine Cervix Cancer
20%
HIV
15%
Human Immunodeficiency Virus Infection
15%
Anti Human Immunodeficiency Virus Agent
9%
Vagina Flora
7%
Antiviral Activity
7%
Epileptic Absence
7%
Clinical Trial
7%
Uterine Cervix Carcinoma in Situ
7%
Placebo-Controlled Study
7%
Placebo
7%